Abstract
The waning effectiveness of established tuberculosis treatments due to the rise of multi and extensively drugresistant strains of Mycobacterium tuberculosis, coupled with the synergism of HIV infection, demands basic research efforts to inform focused drug development programs. Structural genomics projects provide rich sources of information for the rational design of anti-tubercular drugs, aiming to exploit unique and novel protein features and interactions based on atomic resolution structures. This review compiles structures of M. tuberculosis proteins elucidated since January 2007 that are promising avenues for drug design, encompassing proteins involved with known and experimental antituberculosis drugs, metabolism, dealing with the hostile environment of the host organism, and information processing.
Keywords: Tuberculosis, Mycobacterium tuberculosis, structural genomics, protein drug targets, X-ray crystallography
Infectious Disorders - Drug Targets
Title: Advances in Mycobacterium tuberculosis Structural Genomics: Investigating Potential Chinks in the Armor of a Deadly Pathogen
Volume: 9 Issue: 5
Author(s): N. Chim, L. M. McMath, M. Beeby and C. W. Goulding
Affiliation:
Keywords: Tuberculosis, Mycobacterium tuberculosis, structural genomics, protein drug targets, X-ray crystallography
Abstract: The waning effectiveness of established tuberculosis treatments due to the rise of multi and extensively drugresistant strains of Mycobacterium tuberculosis, coupled with the synergism of HIV infection, demands basic research efforts to inform focused drug development programs. Structural genomics projects provide rich sources of information for the rational design of anti-tubercular drugs, aiming to exploit unique and novel protein features and interactions based on atomic resolution structures. This review compiles structures of M. tuberculosis proteins elucidated since January 2007 that are promising avenues for drug design, encompassing proteins involved with known and experimental antituberculosis drugs, metabolism, dealing with the hostile environment of the host organism, and information processing.
Export Options
About this article
Cite this article as:
Chim N., McMath M. L., Beeby M. and Goulding W. C., Advances in Mycobacterium tuberculosis Structural Genomics: Investigating Potential Chinks in the Armor of a Deadly Pathogen, Infectious Disorders - Drug Targets 2009; 9 (5) . https://dx.doi.org/10.2174/187152609789105731
DOI https://dx.doi.org/10.2174/187152609789105731 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis of Nitrogen and Oxygen based Pyrazole Derivatives and Its Antitubercular and Antimicrobial Activity
Anti-Infective Agents Patent Selections
Recent Patents on Biotechnology Vitamin D among Patients of Pulmonary and Extrapulmonary Tuberculosis: A Prospective Case-control Study
Current Respiratory Medicine Reviews Mechanism of Action: How Nano-Antimicrobials Act?
Current Drug Targets Structural and Binding Properties of the Active Cell Wall Hydrolase RipA from <i>M. tuberculosis</i>, a Promising Biosensing Molecule for Early Warning Bacterial Detection
Current Medicinal Chemistry Pandemic of Atopic Diseases - A Lack of Microbial Exposure in Early Infancy?
Current Drug Targets - Infectious Disorders Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases
Current Medicinal Chemistry Serum and Bronchoalveolar Lavage Fluid 25(OH)Vitamin D3 Levels in HIV-1 and Tuberculosis: A Cross-Sectional Study from a Tertiary Care Center in North India
Current HIV Research Synthesis of 2,4,6-Trichlorophenyl Hydrazones and their Inhibitory Potential Against Glycation of Protein
Medicinal Chemistry Shikimate Kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: Kinetics and Structural Dynamics of a Potential Molecular Target for Drug Development
Current Medicinal Chemistry Interstitial Lung Disease in Idiopathic Inflammatory Myopathy
Current Rheumatology Reviews Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Thalidomide: A Banned Drug Resurged into Future Anticancer Drug
Current Drug Therapy Pharmacological Targeting of the Inflamed Intestinal Barrier
Current Pharmaceutical Design Review of the Biological Activity of Maslinic Acid
Current Drug Targets Adhesion Molecules and Kinases Involved in γ δ T Cells Migratory Pathways:Implications for Viral and Autoimmune Diseases
Current Medicinal Chemistry Ethanol and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry MIF and the Genetic Basis of Macrophage Responsiveness
Current Immunology Reviews (Discontinued) The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival
Current Drug Targets Recent Updates on Biological Activities of Oxadiazoles
Mini-Reviews in Medicinal Chemistry